Plum SEC
Menu
Korean Market
Privacy Policy
Korean Market
Star Rating
Reset (View All)
★★★★★
★★★★
★★★
★★
★
★
★
★★
★★★
★★★★
★★★★★
All Disclosures
Search
EXCH
REYON PHARMACEUTICAL
★
REYON PHARMACEUTICAL's corporate governance report reveals multiple deficiencies in dividend policy, CEO succession, and internal controls, posing long-term governance risks
06/01/2026, 04:37 PM
PERI
REYON PHARMACEUTICAL
★★★
Reyon Pharm Q1 2026: Operating Loss of 6.7B Won, Net Loss and Deteriorating Financial Structure
05/15/2026, 05:25 PM